Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RandoMized, DOuble-bliNd, PlacebO-coNtrolled Trial Of Lasmiditan in a Single Migraine Attack in Japanese Patients SuFfering From Migraine With or WithoUt Aura - the MONONOFU Study

Next Previous
X
Search
Trial Profile

RandoMized, DOuble-bliNd, PlacebO-coNtrolled Trial Of Lasmiditan in a Single Migraine Attack in Japanese Patients SuFfering From Migraine With or WithoUt Aura - the MONONOFU Study

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 27 Sep 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lasmiditan (Primary)
  • Indications Migraine with aura; Migraine without aura
  • Focus Therapeutic Use
  • Acronyms MONONOFU
  • Sponsors Eli Lilly and Company

    • Most Recent Events

    • 22 Sep 2022 Results of sub group analysis assessing the efficacy of lasmiditan across patient and migraine characteristics in Japanese patients with migraine published in the Advances in Therapy.
    • 22 Sep 2022 Results assessing the onset and sustained efficacy of lasmiditan in Japanese patients with migraine, published in the Neurology and Therapy
    • 18 Aug 2022 Results of a post hoc analysis of pooled data from MONONOFU and CENTURION studies assessed the efficacy of lasmiditan, a high affinity and selective 5-HT(1F) receptor agonist, for perimenstrual attacks published in the Cephalalgia

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top